NATURAL ANTIMICROBIALS AND THEIR ROLE IN VAGINAL HEALTH: A SHORT REVIEW
- PMID: 20657710
- PMCID: PMC2908489
NATURAL ANTIMICROBIALS AND THEIR ROLE IN VAGINAL HEALTH: A SHORT REVIEW
Abstract
Lactobacillus species maintain the vaginal ecosystem in a healthy condition by production of antimicrobial substances. Depletion of lactobacilli in the vagina results in bacterial vaginosis (BV), where the normal flora is replaced by several bacterial pathogens, usually Gardnerella vaginalis and obligate anaerobes. BV may cause complications such as premature labor, low birth weight and increased risk of HIV acquisition. The currently recommended antibiotic treatments for BV are not always effective and often lead to reoccurrence of the infection. In many cases, this is due to the antibiotic-resistant forms of the pathogens. Therefore, there is an interest in the development of treatments using antimicrobials derived primarily from Lactobacillus spp., such as ribosomally produced antimicrobial peptides (bacteriocins) and lactic acid. These substances effectively inhibit pathogenic bacteria, are safe and do not pose any threat to healthy vaginal Lactobacillus spp. It may be possible to find an effective treatment against BV while reducing the infection's reoccurrence and the treatment-related complications through hurdle technology. This would be achieved by combining antimicrobials produced by Lactobacillus spp. with different natural antimicrobials obtained from plants or other non-pathogenic organisms.
Similar articles
-
Bacterial vaginosis, vaginal flora patterns and vaginal hygiene practices in patients presenting with vaginal discharge syndrome in The Gambia, West Africa.BMC Infect Dis. 2005 Mar 9;5:12. doi: 10.1186/1471-2334-5-12. BMC Infect Dis. 2005. PMID: 15757510 Free PMC article.
-
Effectiveness of the two microorganisms Lactobacillus fermentum LF15 and Lactobacillus plantarum LP01, formulated in slow-release vaginal tablets, in women affected by bacterial vaginosis: a pilot study.J Clin Gastroenterol. 2014 Nov-Dec;48 Suppl 1:S106-12. doi: 10.1097/MCG.0000000000000226. J Clin Gastroenterol. 2014. PMID: 25291116 Clinical Trial.
-
Natural antimicrobials subtilosin and lauramide arginine ethyl ester synergize with conventional antibiotics clindamycin and metronidazole against biofilms of Gardnerella vaginalis but not against biofilms of healthy vaginal lactobacilli.Pathog Dis. 2015 Jul;73(5):ftv018. doi: 10.1093/femspd/ftv018. Epub 2015 Apr 2. Pathog Dis. 2015. PMID: 25838136
-
Cholesterol-Dependent Cytolysins Produced by Vaginal Bacteria: Certainties and Controversies.Front Cell Infect Microbiol. 2020 Jan 10;9:452. doi: 10.3389/fcimb.2019.00452. eCollection 2019. Front Cell Infect Microbiol. 2020. PMID: 31998661 Free PMC article. Review.
-
Probiotics for the treatment of women with bacterial vaginosis.Clin Microbiol Infect. 2007 Jul;13(7):657-64. doi: 10.1111/j.1469-0691.2007.01688.x. Clin Microbiol Infect. 2007. PMID: 17633390 Review.
Cited by
-
Vaginal microbiome: rethinking health and disease.Annu Rev Microbiol. 2012;66:371-89. doi: 10.1146/annurev-micro-092611-150157. Epub 2012 Jun 28. Annu Rev Microbiol. 2012. PMID: 22746335 Free PMC article. Review.
-
Bacterial vaginosis: Etiology and modalities of treatment-A brief note.J Pharm Bioallied Sci. 2011 Oct;3(4):496-503. doi: 10.4103/0975-7406.90102. J Pharm Bioallied Sci. 2011. PMID: 22219582 Free PMC article.
-
Gemini Cationic Amphiphiles Control Biofilm Formation by Bacterial Vaginosis Pathogens.Antimicrob Agents Chemother. 2017 Nov 22;61(12):e00650-17. doi: 10.1128/AAC.00650-17. Print 2017 Dec. Antimicrob Agents Chemother. 2017. PMID: 28893789 Free PMC article.
-
Saccharomyces cerevisiae-based probiotic as novel anti-microbial agent for therapy of bacterial vaginosis.Virulence. 2018 Dec 31;9(1):954-966. doi: 10.1080/21505594.2018.1464362. Virulence. 2018. PMID: 29683763 Free PMC article.
-
Bacteriocins as a new generation of antimicrobials: toxicity aspects and regulations.FEMS Microbiol Rev. 2021 Jan 8;45(1):fuaa039. doi: 10.1093/femsre/fuaa039. FEMS Microbiol Rev. 2021. PMID: 32876664 Free PMC article. Review.
References
-
- Al-Mushrif S, Jones BM. A study of the prevalence of hydrogen peroxide generating lactobacilli in bacterial vaginosis: the determination of H2O2 concentrations generated, in vitro, by isolated strains and the levels found in vaginal secretions of women with and without infection. Journal of Obstetrics and Gynecology. 1998;18:63–67. - PubMed
-
- Andersch B, Lindell D, Dahlen I, Brandberg A. Bacterial vaginosis and the effect of intermittent prophylactic treatment with an acid lactate gel. Gynecologic and Obstetric Investigation. 1990;30:114–119. - PubMed
-
- Anukam KC, Osazuwa E, Ahonkhai I, Ngwu M, Osemene GI, Bruce AA, Reid G. Augmentation of antimicrobial metronidazole therapy of bacterial vaginosis with oral probiotic Lactobacillus rhamnosus GR-1 and Lactobacillus reuteri RC-14: randomized, double-blind, placebo controlled trial. Microbes and Infection. 2006a;8:1450–1454. - PubMed
-
- Anukam KC, Osazuwa E, Osemene GI, Ehigiagbe F, Bruce AW, Reid G. Clinical study comparing probiotic Lactobacillus GR-1 and RC-14 with metronidazole vaginal gel to treat symptomatic bacterial vaginosis. Microbes and Infection. 2006b;8:2772–2776. - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous